Norepinephrine-Induced DNA Damage in Ovarian Cancer Cells.
DNA lesions
adrenergic receptors
cisplatin
epinephrine
norepinephrine
ovarian cancer
stress
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
24 Mar 2020
24 Mar 2020
Historique:
received:
27
02
2020
revised:
18
03
2020
accepted:
20
03
2020
entrez:
28
3
2020
pubmed:
28
3
2020
medline:
15
12
2020
Statut:
epublish
Résumé
Multiple studies have shown that psychological distress in epithelial ovarian cancer (EOC) patients is associated with worse quality of life and poor treatment adherence. This may influence chemotherapy response and prognosis. Moreover, although stress hormones can reduce cisplatin efficacy in EOC treatment, their effect on the integrity of DNA remains poorly understood. In this study, we investigated whether norepinephrine and epinephrine can induce DNA damage and modulate cisplatin-induced DNA damage in three EOC cell lines. Our data show that norepinephrine and epinephrine exposure led to increased nuclear γ-H2AX foci formation in EOC cells, a marker of double-strand DNA breaks. We further characterized norepinephrine-induced DNA damage by subjecting EOC cells to alkaline and neutral comet assays. Norepinephrine exposure caused DNA double-strand breaks, but not single-strand breaks. Interestingly, pre-treatment with propranolol abrogated norepinephrine-induced DNA damage indicating that its effects may be mediated by β-adrenergic receptors. Lastly, we determined the effects of norepinephrine on cisplatin-induced DNA damage. Our data suggest that norepinephrine reduced cisplatin-induced DNA damage in EOC cells and that this effect may be mediated independently of β-adrenergic receptors. Taken together, these results suggest that stress hormones can affect DNA integrity and modulate cisplatin resistance in EOC cells.
Identifiants
pubmed: 32213975
pii: ijms21062250
doi: 10.3390/ijms21062250
pmc: PMC7139728
pii:
doi:
Substances chimiques
H2AX protein, human
0
Histones
0
Cisplatin
Q20Q21Q62J
Norepinephrine
X4W3ENH1CV
Epinephrine
YKH834O4BH
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIMHD NIH HHS
ID : U54 MD007579
Pays : United States
Organisme : NIGMS NIH HHS
ID : R25GM082406
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM103475
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA163068
Pays : United States
Organisme : NIMHD NIH HHS
ID : U54 MD007587
Pays : United States
Organisme : NCI NIH HHS
ID : U54CA163068
Pays : United States
Organisme : NIMHD NIH HHS
ID : U24 MD015970
Pays : United States
Organisme : NIGMS NIH HHS
ID : R25 GM096955
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA092309
Pays : United States
Organisme : NCI NIH HHS
ID : U54 CA163071
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20GM103475
Pays : United States
Organisme : NCI NIH HHS
ID : U54CA163071
Pays : United States
Organisme : NIGMS NIH HHS
ID : R25 GM082406
Pays : United States
Organisme : NIMHD NIH HHS
ID : U54MD007579
Pays : United States
Références
Oncogene. 2003 Oct 20;22(47):7265-79
pubmed: 14576837
PLoS One. 2013 Sep 04;8(9):e72303
pubmed: 24023735
Redox Biol. 2014 Jan 09;2:457-65
pubmed: 24624335
Nat Rev Mol Cell Biol. 2010 Mar;11(3):220-8
pubmed: 20177397
Biochem Biophys Res Commun. 2005 Apr 15;329(3):888-97
pubmed: 15752739
Endocrinology. 1996 Dec;137(12):5597-604
pubmed: 8940389
Cancer Causes Control. 2016 May;27(5):661-8
pubmed: 27023470
Nature. 1992 Jul 2;358(6381):15-6
pubmed: 1614522
J Ovarian Res. 2009 Jan 14;2:2
pubmed: 19144189
PLoS One. 2014 Sep 17;9(9):e103988
pubmed: 25230021
J Clin Oncol. 2012 Aug 10;30(23):2885-90
pubmed: 22802321
Psychoneuroendocrinology. 2007 Jun;32(5):470-9
pubmed: 17459596
Nat Rev Cancer. 2003 Jul;3(7):502-16
pubmed: 12835670
Endocrinology. 2012 Mar;153(3):1472-83
pubmed: 22234472
Mol Cell Biol. 2003 Aug;23(16):5706-15
pubmed: 12897142
Br J Cancer. 2015 Apr 28;112(9):1461-70
pubmed: 25880007
Sci Rep. 2018 Mar 9;8(1):4306
pubmed: 29523854
Clin Cancer Res. 2006 Jan 15;12(2):369-75
pubmed: 16428474
Clin Cancer Res. 2016 Apr 1;22(7):1713-24
pubmed: 26581245
Radiat Res. 2014 Feb;181(2):111-30
pubmed: 24397478
J Psychosom Res. 2004 Oct;57(4):353-8
pubmed: 15518669
Free Radic Biol Med. 2011 Jan 1;50(1):139-47
pubmed: 21075203
Environ Health Perspect. 1993 Dec;101 Suppl 5:35-44
pubmed: 8013423
Psychoneuroendocrinology. 2009 Nov;34(10):1533-41
pubmed: 19560278
Gynecol Oncol. 2000 Sep;78(3 Pt 1):302-8
pubmed: 10985884
Gynecol Oncol. 2016 Dec;143(3):521-525
pubmed: 27693123
Eur J Med Res. 1996 Sep 20;1(11):528-32
pubmed: 9438155
J Clin Invest. 2010 May;120(5):1515-23
pubmed: 20389021
Cell. 2017 Feb 9;168(4):644-656
pubmed: 28187286
Neoplasia. 2015 Oct;17(10):789-803
pubmed: 26585234
Brain Behav Immun. 2011 Feb;25(2):250-5
pubmed: 20955777
J Biol Chem. 2007 Oct 12;282(41):29919-26
pubmed: 17716980
Cancer. 2005 Jul 15;104(2):305-13
pubmed: 15954082
Oncotarget. 2015 Feb 28;6(6):4266-73
pubmed: 25738355
Chem Biol Interact. 2009 May 15;179(2-3):71-80
pubmed: 18929549
Teratog Carcinog Mutagen. 2003;Suppl 2:69-81
pubmed: 14691981
Nature. 2009 Oct 22;461(7267):1071-8
pubmed: 19847258
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1920-5
pubmed: 12578963
Clin Cancer Res. 2018 Jul 1;24(13):3163-3175
pubmed: 29615458
Clin Cancer Res. 2003 Oct 1;9(12):4514-21
pubmed: 14555525
Nat Med. 2006 Aug;12(8):939-44
pubmed: 16862152
Nat Rev Cancer. 2008 Mar;8(3):193-204
pubmed: 18256616
Cancer Res. 2007 Nov 1;67(21):10389-96
pubmed: 17974982
J Cell Mol Med. 2007 Jan-Feb;11(1):156-70
pubmed: 17367510
Cancer Res. 1992 Aug 1;52(15):4196-9
pubmed: 1638534
Psychosom Med. 2005 Jul-Aug;67(4):638-42
pubmed: 16046380
Radiat Res. 2013 Mar;179(3):323-31
pubmed: 23368416
Gynecol Oncol. 2012 Nov;127(2):375-8
pubmed: 22819786
Stress. 2013 Jan;16(1):114-21
pubmed: 22506837
J Biol Chem. 2010 Nov 12;285(46):35462-70
pubmed: 20826776
J Clin Oncol. 2005 Oct 1;23(28):7105-13
pubmed: 16192594
J Biol Chem. 1998 Jan 2;273(1):1-4
pubmed: 9417035
EMBO J. 2008 Feb 20;27(4):589-605
pubmed: 18285820
CA Cancer J Clin. 2017 Jan;67(1):7-30
pubmed: 28055103
J Bioanal Biomed. 2015;7(3):75-80
pubmed: 26167254
Cancer Epidemiol Biomarkers Prev. 2016 Dec;25(12):1587-1594
pubmed: 27587791
Gynecol Oncol. 2019 Sep;154(3):524-530
pubmed: 31353053
J Biol Chem. 1998 Mar 6;273(10):5858-68
pubmed: 9488723
J Phys Chem B. 2010 Jan 14;114(1):675-80
pubmed: 19938853
Cancer. 2015 Oct 1;121(19):3444-51
pubmed: 26301456
Microsc Res Tech. 2002 Dec 15;59(6):495-502
pubmed: 12467025
Endocrine. 2001 Jul;15(2):187-92
pubmed: 11720244